Video 10 Jul 2020

Message from Thomas Cueni at AMR Action Fund launch event in Tokyo on 10 July 2020

Video 9 Jul 2020

Launch Event 9 July | New initiative takes on the antibiotic innovation challenge

The world is losing its most powerful tool in healthcare: antibiotics. The reason is rapidly rising antibiotic-resistant infections – also called antimicrobial resistance, or AMR.

Press release 9 Jul 2020

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion. This partnership aims to bring 2 to 4 new antibiotics to patients by the end of the decade and facilitate needed long-term policy solutions.

Expert insight 2 Jul 2020

Reinforcing Business Integrity for APEC Health Systems Amidst COVID-19

Authors: Dr. Jeff Blackmer, Mr. Thomas Cueni, Mr. Gaston Fernandez, Ms. Nancy Travis, Mr. Russell Williams The dual health and economic crisis resulting from COVID-19 has brought into sharp focus the importance of ethical business conduct. Emergency government measures, widespread economic and social disruption, as well as unscrupulous actors taking advantage of the current situation...

Report 2 Jul 2020

IFPMA Global Code Comparison Report 2020

Statement 26 Jun 2020

IFPMA Statement – Access to COVID-19 Tools Accelerator (ACT-Accelerator) Investment Case

Geneva, 26 June 2020: Today, we face the first global pandemic in living memory; affecting hundreds of millions of people around the world. Never before has there been so much hope placed in finding safe and effective vaccines, produced in sufficient quantities; with the promise to ensure no one is left behind. IFPMA’s members, which...

Video 18 Jun 2020

IFPMA Code of Practice eLearning (Video)

Infographic 16 Jun 2020

Collaborating to end Neglected Tropical Diseases

Report 16 Jun 2020

Collaborating to end Neglected Tropical Diseases: Catalyzing Innovation and Partnerships

Interventions in Neglected Tropical Diseases (NTDs) represent some of the largest public health interventions globally, and the innovative biopharmaceutical industry has always been an active partner throughout. The innovative biopharmaceutical industry’s support to NTDs is multi-faceted, and R&D activities are complemented by medicine donations and programs to strengthen health system capacities and improve public awareness...

Position paper 10 Jun 2020

IFPMA Position Paper – Call to Action from Vaccines Heads of Quality

Press release 8 Jun 2020

Global Pharma Body Names New Communications Director

Geneva, 8 June, 2020: The industry body representing research-based biopharmaceutical companies and regional and national associations across the world has appointed Abigail Jones as its new Communications Director. Abigail was previously a founding partner at Acumen Public Affairs. Given her wide international experience, her in-depth knowledge of global health policy and news agenda, Abigail will...

Expert insight 4 Jun 2020

What will it take to produce the billions of vaccines needed against COVID-19?

Published on Thomas Cueni’s LinkedIn profile. COVID-19 is not business as usual for any of us, especially not for the pharmaceutical industry. As we enter into the sixth month of the COVID-19 pandemic, I think it is no understatement to say that the global biopharmaceutical industry has been at the forefront of efforts from day...